{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:38:39Z","timestamp":1792175919501,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T00:00:00Z","timestamp":1377216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00108-013-3313-9","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T09:31:06Z","timestamp":1377077466000},"page":"1383-1392","source":"Crossref","is-referenced-by-count":7,"title":["Medikament\u00f6se Therapie der infekti\u00f6sen Diarrh\u00f6","Drug therapy of infectious diarrhea"],"prefix":"10.1007","volume":"54","author":[{"given":"C.","family":"L\u00fcbbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,23]]},"reference":[{"key":"3313_CR1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/378746","volume":"37","author":"Adachi","year":"2003","unstructured":"Adachi JA, Ericsson CD, Jiang ZD et al (2003) Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis 37:1165\u20131171","journal-title":"Clin Infect Dis"},{"key":"3313_CR2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1469-0691.2009.03099.x","volume":"15","author":"Bauer","year":"2009","unstructured":"Bauer MP, Kuijper EJ, Van Dissel JT et al (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15:1067\u20131079","journal-title":"Clin Microbiol Infect"},{"key":"3313_CR3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/QCO.0b013e32833229ce","volume":"22","author":"Bauer","year":"2009","unstructured":"Bauer MP, Van Dissel JT, Kuijper EJ (2009) Clostridium difficile: controversies and approaches to management. Curr Opin Infect Dis 22:517\u2013524","journal-title":"Curr Opin Infect Dis"},{"key":"3313_CR4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ajg.2012.60","volume":"107","author":"Brandt","year":"2012","unstructured":"Brandt LJ, Aroniadis OC, Mellow M et al (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107:1079\u20131087","journal-title":"Am J Gastroenterol"},{"key":"3313_CR5","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1056\/NEJMoa1106482","volume":"365","author":"Buchholz","year":"2011","unstructured":"Buchholz U, Bernard H, Werber D et al (2011) German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 365:1763\u20131770","journal-title":"N Engl J Med"},{"key":"3313_CR6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3201\/eid1404.071023","volume":"14","author":"Burckhardt","year":"2008","unstructured":"Burckhardt F, Friedrich A, Beier D et al (2008) Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis 14:691\u2013692","journal-title":"Emerg Infect Dis"},{"key":"3313_CR7","first-page":"CD006784","volume":"Rev","author":"Christopher","year":"2010","unstructured":"Christopher PR, David KV, John SM et al (2010) Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev:CD006784","journal-title":"Cochrane Database Syst"},{"key":"3313_CR8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","volume":"31","author":"Cohen","year":"2010","unstructured":"Cohen SH, Gerding DN, Johnson S et al (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31:431\u2013455","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3313_CR9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00108-011-2862-z","volume":"52","author":"Epple","year":"2011","unstructured":"Epple HJ, Zeitz M (2011) Infectious enteritis. Internist 52:1038\u20131046","journal-title":"Internist"},{"key":"3313_CR10","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/521860","volume":"46","author":"Gerding","year":"2008","unstructured":"Gerding DN, Muto CA, Owens RC Jr (2008) Treatment of Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S32\u2013S42","journal-title":"Clin Infect Dis"},{"key":"3313_CR11","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","volume":"379","author":"Harris","year":"2012","unstructured":"Harris JB, Larocque RC, Qadri F et al (2012) Cholera. Lancet 379:2466\u20132476","journal-title":"Lancet"},{"key":"3313_CR12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jac\/dkr508","volume":"67","author":"Hensgens","year":"2011","unstructured":"Hensgens MP, Goorhuis A, Dekkers OM et al (2011) Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 67:742\u2013748","journal-title":"J Antimicrob Chemother"},{"key":"3313_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1756283X11398734","volume":"4","author":"Hong","year":"2011","unstructured":"Hong KS, Kim JS (2011) Rifaximin for the treatment of acute infectious diarrhea. Therap Adv Gastroenterol 4:227\u2013235","journal-title":"Therap Adv Gastroenterol"},{"key":"3313_CR14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7326\/0003-4819-157-12-201212180-00563","volume":"157","author":"Johnston","year":"2013","unstructured":"Johnston BC, Ma SS, Goldenberg JZ et al (2013) Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 157:878\u2013888","journal-title":"Ann Intern Med"},{"key":"3313_CR15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(96)01180-4","volume":"348","author":"Khan","year":"1996","unstructured":"Khan WA, Bennish Ml, Seas C et al (1996) Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139. Lancet 348:296\u2013300","journal-title":"Lancet"},{"key":"3313_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOG.0b013e3283413763","volume":"27","author":"Kirkpatrick","year":"2010","unstructured":"Kirkpatrick BD, Tribble DR (2010) Update on human Campylobacter jejuni infections. Curr Opin Gastroenterol 27:1\u20137","journal-title":"Curr Opin Gastroenterol"},{"key":"3313_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QCO.0b013e32833da204","volume":"23","author":"Kosek","year":"2010","unstructured":"Kosek M, Yori PP, Olortegui MP (2010) Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas. Curr Opin Infect Dis 23:475\u2013480","journal-title":"Curr Opin Infect Dis"},{"key":"3313_CR18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.gtc.2012.06.009","volume":"41","author":"Krones","year":"2012","unstructured":"Krones E, Hogenauer C (2012) Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am 41:677\u2013701","journal-title":"Gastroenterol Clin North Am"},{"key":"3313_CR19","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1128\/AAC.00314-11","volume":"55","author":"Lehtopolku","year":"2011","unstructured":"Lehtopolku M, Kotilainen P, Haanpera-Heikkinen M et al (2011) Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 55:5939\u20135941","journal-title":"Antimicrob Agents Chemother"},{"key":"3313_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"Louie","year":"2011","unstructured":"Louie TJ, Miller MA, Mullane KM et al (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364:422\u2013431","journal-title":"N Engl J Med"},{"key":"3313_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","volume":"362","author":"Lowy","year":"2010","unstructured":"Lowy I, Molrine DC, Leav BA et al (2010) Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 362:197\u2013205","journal-title":"N Engl J Med"},{"key":"3313_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0030-1256463","volume":"7","author":"L\u00fcbbert","year":"2011","unstructured":"L\u00fcbbert C (2011) Fidaxomicin als Alternative zu Vancomycin bei Clostridium difficile-Infektion. Gastroenterologie up2date 7:74\u201375","journal-title":"Gastroenterologie up2date"},{"key":"3313_CR23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.2012.264","volume":"307","author":"Nitschke","year":"2012","unstructured":"Nitschke M, Sayk F, Hartel C et al (2012) Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 307:1046\u20131052","journal-title":"JAMA"},{"key":"3313_CR24","first-page":"CD001167","volume":"11","author":"Onwuezobe","year":"2012","unstructured":"Onwuezobe IA, Oshun PO, Odigwe CC (2012) Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev 11:CD001167","journal-title":"Cochrane Database Syst Rev"},{"key":"3313_CR25","doi-asserted-by":"crossref","unstructured":"Pillai A, Nelson R (2008) Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev CD004611","DOI":"10.1002\/14651858.CD004611.pub2"},{"key":"3313_CR26","first-page":"23","volume":"3","author":"Robert","year":"2013","unstructured":"Robert Koch-Institut (2013) Aktuelle Statistik meldepflichtiger Infektionskrankheiten, Deutschland. Epidemiol Bull 3:23\u201330","journal-title":"Epidemiol Bull"},{"key":"3313_CR27","unstructured":"Robert Koch-Institut (2011) Ratgeber Infektionskrankheiten \u2013 Merkbl\u00e4tter f\u00fcr \u00c4rzte: Salmonellose (Salmonellen-Gastroenteritis). http:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Salmonellose.html"},{"key":"3313_CR28","unstructured":"Robert Koch-Institut (2012) Ratgeber Infektionskrankheiten \u2013 Merkbl\u00e4tter f\u00fcr \u00c4rzte: Shigellose. http:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Shigellose.html"},{"key":"3313_CR29","first-page":"233","volume":"24","author":"Robert","year":"2009","unstructured":"Robert Koch-Institut (2009) Ratgeber Infektionskrankheiten \u2013 Merkbl\u00e4tter f\u00fcr \u00c4rzte: Clostridium difficile. Epidemiol Bull 24:233\u2013239","journal-title":"Epidemiol Bull"},{"key":"3313_CR30","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMoa054493","volume":"354","author":"Saha","year":"2006","unstructured":"Saha D, Karim MM, Khan WA et al (2006) Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med 354:2452\u20132462","journal-title":"N Engl J Med"},{"key":"3313_CR31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/JCM.02247-06","volume":"45","author":"Taneja","year":"2007","unstructured":"Taneja N (2007) Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India. J Clin Microbiol 45:678\u2013679","journal-title":"J Clin Microbiol"},{"key":"3313_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJMcp031534","volume":"350","author":"Thielman","year":"2004","unstructured":"Thielman NM, Guerrant Rl (2004) Clinical practice. Acute infectious diarrhea. N Engl J Med 350:38\u201347","journal-title":"N Engl J Med"},{"key":"3313_CR33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"Van","year":"2013","unstructured":"Van Nood E, Vrieze A, Nieuwdorp M et al (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368:407\u2013415","journal-title":"N Engl J Med"},{"key":"3313_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00108-010-2789-9","volume":"52","author":"Weis","year":"2011","unstructured":"Weis S, Grimm M (2011) Nosocomial diarrhea. Internist 52:167\u2013177","journal-title":"Internist"},{"key":"3313_CR35","unstructured":"Weis S, John E, Lippmann N et al (2013) Clostridium difficile \u2013 ein Thema nur f\u00fcr den Internisten? Zentralbl Chir (im Druck)"},{"key":"3313_CR36","unstructured":"World Health Organization (2013) Diarrheal disease. Fact Sheet No 330 April 2013. WHO, Genf"},{"key":"3313_CR37","unstructured":"World Health Organization (2006) Oral rehydration salts: production of the new ORS. WHO, Genf"},{"key":"3313_CR38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7326\/0003-4819-117-3-202","volume":"117","author":"Wistrom","year":"1992","unstructured":"Wistrom J, Jertborn M, Ekwall E et al (1992) Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. Ann Intern Med 117:202\u2013208","journal-title":"Ann Intern Med"},{"key":"3313_CR39","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","volume":"342","author":"Wong","year":"2000","unstructured":"Wong CS, Jelacic S, Habeeb Rl et al (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342:1930\u20131936","journal-title":"N Engl J Med"},{"key":"3313_CR40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","volume":"45","author":"Zar","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KM et al (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45:302\u2013307","journal-title":"Clin Infect Dis"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-013-3313-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-013-3313-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-013-3313-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T15:12:33Z","timestamp":1563721953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-013-3313-9"}},"subtitle":["Teil\u00a01: akute Diarrh\u00f6","Part\u00a01: acute diarrhea"],"short-title":[],"issued":{"date-parts":[[2013,8,23]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["3313"],"URL":"https:\/\/doi.org\/10.1007\/s00108-013-3313-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,23]]}}}